AbbVie
ABBV
#30
Rank
ยฃ339.15 B
Marketcap
ยฃ191.96
Share price
4.20%
Change (1 day)
42.25%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of March 2026 : ยฃ55.20 Billion

According to AbbVie's latest financial reports the company's total debt is ยฃ55.20 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2026)

Total debt by year

Year Total debt Change
2025-12-31ยฃ50.11 B-6.33%
2024-12-31ยฃ53.50 B14.79%
2023-12-31ยฃ46.61 B-10.87%
2022-12-31ยฃ52.29 B-7.94%
2021-12-31ยฃ56.80 B-10.02%
2020-12-31ยฃ63.13 B24.07%
2019-12-31ยฃ50.88 B60.24%
2018-12-31ยฃ31.75 B14.85%
2017-12-31ยฃ27.64 B-7.4%
2016-12-31ยฃ29.85 B39.71%
2015-12-31ยฃ21.37 B122.16%
2014-12-31ยฃ9.61 B7.78%
2013-12-31ยฃ8.92 B-7.95%
2012-12-31ยฃ9.69 B31297.55%
2011-12-31ยฃ30.88 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
ยฃ48.28 B-12.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ32.86 B-40.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ43.43 B-21.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ4.97 B-90.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ16.80 B-69.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ35.17 B-36.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ25.69 B-53.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ19.12 B-65.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ0.30 B-99.44%๐Ÿ‡บ๐Ÿ‡ธ USA